Crossref
Computational Assessment and Molecular Docking of Arylhydrazone Ester Derivatives as SARS-CoV-2 Main Protease Inhibitors
New Materials, Compounds and Applications · 2026-04-03
DOI: 10.62476/nmca.10165 ↗At a glance
Journal article in New Materials, Compounds and Applications, published online on 2026-04-03.
Abstract (original language)
Nenhum resumo disponível.
Cite
APA
(2026). Computational Assessment and Molecular Docking of Arylhydrazone Ester Derivatives as SARS-CoV-2 Main Protease Inhibitors. New Materials, Compounds and Applications. https://doi.org/10.62476/nmca.10165
Vancouver
Computational Assessment and Molecular Docking of Arylhydrazone Ester Derivatives as SARS-CoV-2 Main Protease Inhibitors. New Materials, Compounds and Applications. 2026. doi:10.62476/nmca.10165
BibTeX
@article{euvimed2026,
title = {Computational Assessment and Molecular Docking of Arylhydrazone Ester Derivatives as SARS-CoV-2 Main Protease Inhibitors},
journal = {New Materials, Compounds and Applications},
year = {2026},
doi = {10.62476/nmca.10165}
}
EUVIMED